Assertio Therapeutics Announces Sale of NUCYNTA Franchise to Collegium Pharmaceutical for $375.0 Million Read more
Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science Read more
ReAlta Life Sciences Announces FDA Orphan Drug Designation for PIC1 for the Treatment of Hypoxic-Ischemic Encephalopathy Read more
Immix Doses First Patient in USA in its Phase 1b/2a Trial in Patients with Advanced Solid Tumors Read more
Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660 Read more
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus Read more